News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,098 Results
Type
Article (39545)
Company Profile (247)
Press Release (656306)
Section
Business (204099)
Career Advice (2007)
Deals (35412)
Drug Delivery (94)
Drug Development (81008)
Employer Resources (172)
FDA (16153)
Job Trends (14843)
News (345038)
Policy (32496)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49365)
ALS (83)
Alzheimer's disease (1349)
Antibody-drug conjugate (ADC) (108)
Approvals (16155)
Artificial intelligence (228)
Autoimmune disease (14)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (24)
Breast cancer (246)
Cancer (1994)
Cardiovascular disease (160)
Career advice (1673)
Career pathing (29)
CAR-T (139)
Cell therapy (395)
Cervical cancer (18)
Clinical research (65704)
Collaboration (763)
Compensation (453)
Complete response letters (19)
COVID-19 (2580)
CRISPR (35)
C-suite (211)
Cystic fibrosis (98)
Data (1952)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (249)
Diagnostics (6331)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (111)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86207)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111639)
Executive appointments (639)
FDA (17255)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (686)
Gene editing (96)
Generative AI (18)
Gene therapy (276)
GLP-1 (684)
Government (4377)
Grass and pollen (4)
Guidances (48)
Healthcare (18808)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2710)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (86)
Interviews (311)
IPO (16484)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (452)
Leadership (15)
Legal (7899)
Liver cancer (70)
Lung cancer (291)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (265)
MASH (61)
Medical device (13321)
Medtech (13326)
Mergers & acquisitions (19399)
Metabolic disorders (631)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1821)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2422)
Now hiring (37)
Obesity (339)
Opinion (201)
Ovarian cancer (72)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (132)
Partnered (20)
Patents (203)
Patient recruitment (93)
Peanut (46)
People (57080)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20463)
Phase II (28932)
Phase III (21567)
Pipeline (1026)
Podcasts (44)
Policy (110)
Postmarket research (2563)
Preclinical (8653)
Press Release (64)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (355)
Real estate (5900)
Recruiting (65)
Regulatory (22134)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (120)
Series B (78)
Service/supplier (11)
Sickle cell disease (50)
Southern California (2098)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3571)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (25)
United States (21113)
Vaccines (657)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (241)
Last 7 days (703)
Last 30 days (2746)
Last 365 days (33640)
2025 (7996)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (49)
Alaska (7)
Arizona (224)
Arkansas (13)
Asia (37705)
Australia (6163)
California (5520)
Canada (1867)
China (474)
Colorado (245)
Connecticut (256)
Delaware (127)
Europe (80833)
Florida (819)
Georgia (193)
Idaho (57)
Illinois (496)
India (23)
Indiana (290)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (826)
Massachusetts (4147)
Michigan (209)
Minnesota (369)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1575)
New Mexico (28)
New York (1586)
North Carolina (916)
North Dakota (7)
Northern California (2422)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1253)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2098)
Tennessee (92)
Texas (823)
Utah (164)
Virginia (128)
Washington D.C. (57)
Washington State (512)
West Virginia (3)
Wisconsin (49)
696,098 Results for "enterin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS
Willow Biosciences Inc. today announced a collaboration with Enterin, Inc. to develop new sustainable manufacturing routes to their key intermediates and active pharmaceutical ingredients (APIs).
January 16, 2024
·
4 min read
Drug Development
Enterin Announces the Start of a First-in-Human Study of ENT-03 in Obesity and Type 2 Diabetes
Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, today announced the start of a Phase 1a study in obesity and Type 2 diabetes (IND #155001).
June 5, 2023
·
2 min read
Pharm Country
Enterin announces FDA acceptance of an investigator sponsored IND to treat a patient with prodromal multisystem atrophy (MSA) with ENT-01
Enterin Inc. announces the acceptance by the U.S. Food and Drug Administration (FDA) of an investigator sponsored Investigational New Drug (IND) application (166532) to treat a patient with prodromal multisystem atrophy (MSA) with ENT-01.
May 31, 2023
·
3 min read
Pharm Country
Enterin Presents Data Demonstrating Strong Benefit of ENT-03 on Body Weight, Adiposity and Blood Glucose Vs. Semaglutide in a Diet Induced Obesity Mouse ModelData presented at the American Diabetes Association 83rd Scientific Sessions
Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, presented in vivo data demonstrating benefit on body weight, adiposity and blood glucose of ENT-03 compared to semaglutide in an obese, diabetic animal model, with persistence of benefit on weight beyond treatment.
June 24, 2023
·
4 min read
Business
Enterin Announces New Funding and Appointment of David Vogel to Its Board of Directors
Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company developing novel treatments for neurodegenerative and metabolic diseases, announces that David Vogel has joined the Board of Directors.
October 3, 2022
·
2 min read
Business
Enterin and Parkinson’s UK Announce Research Collaboration in Parkinson’s Dementia
Enterin Inc. announces a collaboration with the Parkinson’s Virtual Biotech, the drug development and discovery arm of Parkinson’s UK. A new phase 2 trial will study the effects of ENT-01 on Parkinson’s Disease -associated dementia.
October 13, 2022
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Alcon Agrees to Acquire LENSAR, Inc.
March 25, 2025
·
9 min read
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
Press Releases
SNBL and Tasso, Inc. to Establish Joint Venture in Japan
March 28, 2025
·
2 min read
1 of 69,610
Next